实施欧洲癌症行为准则的前景:波兰的教训
Joanna Kufel-Grabowska1, Jacek Jassem1
1Department and Clinic of Oncology and Radiotherapy, Medical University of Gdańsk, Poland.
Health policy (Amsterdam, Netherlands)
|February 18, 2026
概括
在波兰实施欧洲癌症行为准则 (ECCP) 面临的障碍包括人员短缺和不平等的准入. 解决这些问题需要劳动力,组织和文化变化,以实现更好的癌症护理公平.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 患者权利 患者权利
背景情况:
- 欧洲癌症行为准则 (ECCP) 概述了十项患者权利,以提高癌症护理的公平性,质量和以患者为中心.
- 对于ECCP的国家实施数据,特别是在中欧和东欧,很少.
研究的目的:
- 评估在波兰实施"欧洲癌症行为准则" (ECCP) 的可行性.
- 评估国家对ECCP采用准备情况,以确定实施挑战和机会.
主要方法:
- 一个2024年横截面的在线调查分发给波兰的瘤专家和精神瘤学家.
- 每个ECCP权利的可行性都以5分的利克尔特级别评价,并通过对自由文本评论的专题分析来补充.
主要成果:
- 225名专家提供了可行性评级;345人提交了意见. 被认为是最可行的权利包括获取信息,共享决策和优先讨论.
- 在实现平等获得最佳护理,结构化的幸存者/康复计划和多学科团队护理方面,确定了重大挑战.
- 报告的关键障碍是人员短缺,咨询时间不足,诊断/治疗机会差异以及普遍的文化态度.
结论:
- 在波兰成功实施ECCP需要克服劳动力,组织和文化障碍.
- 改进的优先事项包括建立国家临床试验注册,加强多学科单位,加强康复,息护理和沟通培训.
- 拟议的行动被认为是可行的,并可能被转移到其他欧洲医疗保健系统.
相关概念视频
Cancer Survival Analysis
788
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
788
Cancer Prevention
8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.2K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer-Critical Genes I: Proto-oncogenes
11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K


